Dodecyl creatine ester-loaded nanoemulsion as a promising therapy for creatine transporter deficiency - Université d'Angers Accéder directement au contenu
Article Dans Une Revue Nanomedicine (London, England) Année : 2019

Dodecyl creatine ester-loaded nanoemulsion as a promising therapy for creatine transporter deficiency

Résumé

Creatine transporter (CrT) deficiency is an X-linked intellectual disability caused by mutations of CrT. This work focus on the preclinical development of a new therapeutic approach based on a microemulsion (ME) as drug delivery system for dodecyl creatine ester (DCE). DCE-ME was prepared by titration method. Novel object recognition (NOR) tests were performed before and after DCE-ME treatment on mice. Intranasal administration with DCE-ME improved NOR performance in mice. mice treated with DCE-ME had increased striatal ATP levels mainly in the striatum compared with vehicle-treated mice which was associated with increased expression of synaptic markers. These results highlight the potential value of DCE-ME as promising therapy for creatine transporter deficiency.

Dates et versions

hal-02616077 , version 1 (24-05-2020)

Identifiants

Citer

Gabriela Veroniva Ullio Gamboa, Kenea Udobi, Sophie Dézard, Marla Perna, Keila Miles, et al.. Dodecyl creatine ester-loaded nanoemulsion as a promising therapy for creatine transporter deficiency. Nanomedicine (London, England), 2019, 14 (12), pp.1579-1593. ⟨10.2217/nnm-2019-0059⟩. ⟨hal-02616077⟩
47 Consultations
1 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More